Search

everythinglearnresearchcommunity

for

Search:↓

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Lupus can cause hair loss and nail changes, with treatments available for both.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Dupilumab for skin problems might reactivate hair loss in some patients.

A new method using visual aids to diagnose hair diseases was effective after brief training.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Androgenetic alopecia in women needs more research and better management strategies.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Children with loose anagen hair have easily pluckable hair due to root sheath problems, and it might improve without treatment.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Some chemotherapy can cause permanent hair loss.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

A systematic approach is crucial for managing hair loss in women.

Loose Anagen Syndrome is a hair condition where hairs can be easily pulled out, mainly affecting young girls, and may improve on its own or with treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.